BOZEN, Italy -
- Strategic Partnership Announced With Health Robotics
Health Robotics today announced that it has signed an exclusive five-year strategic partnership with McKesson for Health Robotics’ CytoCare Robot. The agreement enables McKesson to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. admixtures.
“We are very pleased to have been chosen by Health Robotics as their exclusive CytoCare partner in our core markets of the United States and Canada”, stated David Souerwine, President, McKesson Automation. “CytoCare, a-one-of-its-kind solution, represents an ideal complement to ROBOT-Rx(R) and MedCarousel(R) technologies, and our entire suite of Automation solutions.”
McKesson believes that CytoCare has the potential to become the gold standard for Oncology I.V. admixtures in North America, equally protecting clinicians and patients. The successful installations of the CytoCare Robot in the United States, including the University of Colorado Hospital in Denver, show synergies between CytoCare and both McKesson Automation and other McKesson Provider Technologies market-leading solutions.
“McKesson is the ideal partner for Health Robotics in North America due to its commitment to medication safety, company stability, market footprint, world-class service infrastructure, and complementary oral medication automation technologies. I was extremely impressed to see their manufacturing and customer services operations in Pittsburgh; they are exactly what CytoCare customers need in North America: a knowledgeable, committed, resourceful, and customer-focused organization. This is precisely what Health Robotics requires at this moment in time to take CytoCare to the next level of market acceptance and customer-service focus in North America. I’m sure this is just the beginning of a long-term partnership expanding into manufacturing and other fields of I.V. Robotics Automation”, stated Werner Rainer, Chairman and CEO of Health Robotics.
About Health Robotics:
Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to ease global hospitals’ growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, visit www.health-robotics.com
About McKesson:
McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. McKesson has been in continuous operation for more than 175 years, making it the longest-operating company in healthcare today. Over the course of its history, McKesson has grown by providing pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. For more information, visit www.mckesson.com
For additional information, please contact: Health Robotics S.r.l. Gaspar G. DeViedma Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100 USA: +1-609-980-7976 EUROPE: +39-346-963-4934 gaspar.deviedma@health-robotics.com McKesson Corporation Clay Courville Vice President, Marketing +1-724-741-8111 clay.courville@mckesson.com
Source: Health Robotics
For additional information, please contact: Health Robotics S.r.l.: Gaspar G. DeViedma, Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100, USA: +1-609-980-7976, EUROPE: +39-346-963-4934, gaspar.deviedma at health-robotics.com; McKesson Corporation: Clay Courville, Vice President, Marketing, +1-724-741-8111, clay.courville at mckesson.com
Related Press Releases
Tosho's Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic PartnershipSeptember 6th, 2009 BOZEN, Sud-Tyrol, Italy - Health Robotics today announced that after a successful first year of cooperation in Japan with Tosho Inc., the companies signed this week a contract renewal of the CytoCare(TM) and i.v.STATION(TM) exclusive distribution agreements, and an expansion of their strategic relationship to include future joint-development projects in their respective areas of Pharmacy Automation expertise. "TOSHO is a model partner for Health Robotics to seek additional partners in other regions of the world, as we continue to expand our global presence: highly-competent and experienced senior executives, large pharmacy automation footprint, company stability, world-class engineering support, and complementary oral medication automation technologies.
Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare PartnershipAugust 23rd, 2009 BOZEN, Italy - Health Robotics today reported that on the heels of its recent partnership announcement with McKesson, it has received categorical support from virtually all of its 13 North American customers in just a few days since the partnership was publicly announced. While several customers' hospital policies prevent them from publicly commenting on industry events, a few reactions to the McKesson-Health Robotics partnership [CytoCare Robot only] were cleared for publication.
Celesio Acquires Majority Stake in Number One Brazilian Pharmaceutical Wholesaler PanpharmaJuly 9th, 2009 STUTTGART, Germany -
- Celesio CEO Dr Fritz Oesterle: No Pharmacy Chain Planned in Brazil
The supervisory board of Celesio AG has today approved the majority holding of 50.1 per cent in pharmaceutical wholesaler Panpharma. This step into one of the most attractive and strongest-growing pharmaceutical markets world-wide is part of Celesio's growth strategy.
Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South AmericaJune 28th, 2009 BOZEN , Italy - Health-Robotics today announced that it has signed an exclusive 5-year strategic partnership with Grifols S.A., the leading Pharmacy Automation provider in Spain, Portugal, and South America. Grifols desires to safely, accurately, and cost-effectively automate the preparation of non-hazardous IV Admixtures with Health Robotics' i.v.STATION Robot.
Talk to Your Pharmacist if You Want to Avoid Summer HorrordaysJune 3rd, 2009 LONDON - Millions of Brits are dicing with disaster and placing their health at risk when taking overseas holidays, research from the Royal Pharmaceutical Society of Great Britain (RPSGB) reveals. The RPSGB's Holiday Health report, released today, shows our laid-back attitude to our well-being can quickly turn perfect holidays into perfectly ghastly experiences.
RPSGB Warns Against Counterfeit Drugs for Swine FluApril 28th, 2009 LONDON - The Royal Pharmaceutical Society of Great Britain (RPSGB) today issued a warning to the public about the risks of buying online medicines for swine influenza, such as Tamiflu or Relenza. David Pruce, RPSGB Director of Policy said:
"With the current fears about swine flu, we are concerned that unscrupulous people are exploiting the public's fears about swine flu by offering to sell the antiviral drugs Tamiflu and Relenza over the internet.
Society Responds to Guidance on Oral Salicylate Gels in Under-16sApril 22nd, 2009 LONDON - Parents and caregivers concerned about the use of Bonjela and Bonjela Cool Mint Gel on children under the age of 16 should consult their pharmacist, the Royal Pharmaceutical Society of Great Britain (RPSGB) recommends. The advice comes after guidance issued by the Medicines and Healthcare Regulatory products Agency (MHRA) advised that products containing salicylate salts, like Bonjela and Bonjela Cool Mint Gel, should not be used for children under the age of 16.
Launch of Orlistat as Pharmacy Medicine Welcomed by SocietyApril 19th, 2009 LONDON - The launch of anti-obesity drug orlistat as a pharmacy medicine this week is a step in the right direction for patients needing effective weight-management care and expert advice, the Royal Pharmaceutical Society of Great Britain (RPSGB) said today. Pharmacists now have the ability to dispense orlistat after conducting a comprehensive consultation with a patient, a move the RPSGB's Director of Policy, David Pruce, said gave the public convenient access to a proven weight-loss aid.
Society Urges Caution When Buying Medicines OnlineApril 15th, 2009 LONDON - The Royal Pharmaceutical Society of Great Britain is urging the public to be aware of the risks when purchasing medicines online, following a survey released by GP magazine. The survey shows one in four GPs has treated patients for adverse reactions to medicines bought on the Internet.
The Dangers of Faking itMarch 23rd, 2009 LONDON - Counterfeit medicine is posing an increasing risk to the publics' health
as the amount being sold online and through other sources grows
internationally, according to the Royal Pharmaceutical Society of Great
Britain (RPSGB) and the Medicines and Healthcare products Regulatory Agency
(MHRA). In an effort to raise public awareness of fake medicine and its dangers,
the RPSGB and MHRA have teamed up to produce new patient guidance, which will
be issued to all pharmacies in Great Britain over the next two months.
Related News
People have risky sex as they're too shy to buy condomsJuly 28th, 2009 WASHINGTON - One out of 10 men said in a recent survey they have had unprotected sex because they were too embarrassed to buy condoms from a pharmacy. This is the finding of an online pharmacy mastersdirect.com, revealing people's opinions about their most embarrassing health problems.
Fla. pharmacy tells AP it made mistake in making medication for polo horses that diedApril 23rd, 2009 Pharmacy says it goofed in making drugs for horsesWEST PALM BEACH, Fla. — A Florida pharmacy has told The Associated Press it incorrectly prepared a medication for 21 polo horses that died over the weekend while preparing to play in a championship match.
Fla. pharmacy tells AP it made mistake in making medication for polo horses that diedApril 23rd, 2009 Pharmacy tells AP made mistake in polo horse drugWEST PALM BEACH, Fla. — A Florida pharmacy has told The Associated Press it incorrectly prepared a medication for 21 polo horses that died over the weekend while preparing to play in a championship match.
Fla. pharmacy official tells AP the business made mistake in supplement for dead polo horsesApril 23rd, 2009 Pharmacy: Mistake made in polo horse supplementWEST PALM BEACH, Fla. — An official at a Florida pharmacy tells The Associated Press that the business incorrectly prepared a supplement for 21 polo horses that died over the weekend before a championship match.
Ford India doubling capacitySeptember 3rd, 2009 CHENNAI - Car manufacturer Ford India Pvt Ltd, which is doubling its production capacity to 200,000 units a year and setting up a 250,000 units engine-and-power train plant near here at an outlay of $500 million has started hiring fresh hands, said a top company official Thursday. "We have already hired 400 new hands, taking the total workforce in the factory to around 2,000.
Frito-Lay to invest Rs.500 crore over three years (Lead)June 4th, 2009 NEW DELHI - Frito-Lay, the food division of beverage major PepsiCo India, plans to spend about Rs.500 crore over the next three years on its entire product range in India, a top official said here Thursday during the launch of a new baked savoury cracker, Aliva. "We will be investing about Rs.500 crore on our entire food portfolio over three years," Gautham Mukkavilli, Frito-Lay India chief executive and PepsiCo India president told reporters.
Specially-abled kids take equine therapy in BangaloreAugust 26th, 2009 BANGALORE - Many specially-abled kids in Bangalore undertook Equine therapy for improvement in health and developing confidence in their lives on Tuesday (August 25). Equine therapy or, horse therapy is only a few years old in India.
AP Newsbreak: Fla. pharmacy tells AP it made mistake in making supplement for dead polo horsesApril 23rd, 2009 AP Newsbreak: Pharmacy made mistake in horse drugWEST PALM BEACH, Fla. — An official at a Florida pharmacy said Thursday the business incorrectly prepared a supplement given to 21 polo horses that died over the weekend while preparing to play in a championship match.
China orders halt to treating Internet addicts with electric shock therapyJuly 14th, 2009 China stops shock therapy for Internet addictsBEIJING — China's Health Ministry has ordered a hospital to stop using electric shock therapy to cure youths of Internet addiction, saying there was no scientific evidence it worked. Linyi Mental Health Hospital in eastern Shandong province used the treatment as part of a four-month program that has so far treated nearly 3,000 youths, the China Youth Daily newspaper has reported, citing the psychiatrist who runs it, Yang Yongxin.
CVS Caremark's 2nd-quarter profit rises 15 percent on better pharmacy, retail salesAugust 4th, 2009 CVS Caremark 2Q profit jumps 15 percentNEW YORK — CVS Caremark, one of the nation's biggest drugstore operators, says its second-quarter profit rose 15 percent, helped by strong pharmacy benefits revenue and a later Easter. The Woonsocket, R.I., company said Tuesday it earned $886.5 million, or 60 cents per share, in the three months ended June 30.
